Hims (HIMS)
As of Oct 23, 2026, Kalshi and Polymarket have settled 86 word markets on Hims’ earnings calls since 2025, on 25 different words. Next call: Nov 9, 2026 (19 words listed).
| Word | Q3’24Nov '24 | Q4’24Feb '25 | Q1’25May '25 | Q2’25Aug '25 | Q3’25year ago | Q4’25Feb '26 | Q1’26May '26 | Q2’26last call | Trend | Last 8 | Scripted | All-time | Probability | Market |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Testosterone | 0 times: Testosterone, Q3’24 Nov '24 | 3 times: Testosterone, Q4’24 Feb '25, counts as said | 7 times: Testosterone, Q1’25 May '25, counts as said | 3 times: Testosterone, Q2’25 Aug '25, counts as said | 8 times: Testosterone, Q3’25 Nov '25, counts as said | 10 times: Testosterone, Q4’25 Feb '26, counts as said | 13 times: Testosterone, Q1’26 May '26, counts as said | 13 times: Testosterone, Q2’26 Aug '26, counts as said | rising | 7/888% | 7/888% | 8/2236% | 95%n=4+tx from settlement history blended with transcripts | 94¢ Kalshi |
| Peptide | 0 times: Peptide, Q3’24 Nov '24 | 6 times: Peptide, Q4’24 Feb '25, counts as said | 6 times: Peptide, Q1’25 May '25, counts as said | 1 time: Peptide, Q2’25 Aug '25, counts as said | 8 times: Peptide, Q3’25 Nov '25, counts as said | 3 times: Peptide, Q4’25 Feb '26, counts as said | 16 times: Peptide, Q1’26 May '26, counts as said | 15 times: Peptide, Q2’26 Aug '26, counts as said | rising | 7/888% | 7/888% | 7/2232% | 95%n=4+tx from settlement history blended with transcripts | 92¢ Kalshi |
| Lab Testing | 0 times: Lab Testing, Q3’24 Nov '24 | 7 times: Lab Testing, Q4’24 Feb '25, counts as said | 5 times: Lab Testing, Q1’25 May '25, counts as said | 7 times: Lab Testing, Q2’25 Aug '25, counts as said | 9 times: Lab Testing, Q3’25 Nov '25, counts as said | 3 times: Lab Testing, Q4’25 Feb '26, counts as said | 2 times: Lab Testing, Q1’26 May '26, counts as said | 4 times: Lab Testing, Q2’26 Aug '26, counts as said | steady | 7/888% | 7/888% | 8/2236% | 90%n=4+tx from settlement history blended with transcripts | 86¢ Kalshi |
| Perimenopause / Menopause | 2 times: Perimenopause / Menopause, Q3’24 Nov '24, counts as said | 1 time: Perimenopause / Menopause, Q4’24 Feb '25, counts as said | 5 times: Perimenopause / Menopause, Q1’25 May '25, counts as said | 4 times: Perimenopause / Menopause, Q2’25 Aug '25, counts as said | 9 times: Perimenopause / Menopause, Q3’25 Nov '25, counts as said | 7 times: Perimenopause / Menopause, Q4’25 Feb '26, counts as said | 6 times: Perimenopause / Menopause, Q1’26 May '26, counts as said | 1 time: Perimenopause / Menopause, Q2’26 Aug '26, counts as said | rising | 8/8100% | 6/875% | 13/2259% | 90%transcripts from the transcript model | 86¢ Kalshi |
| FDA | 2 times: FDA, Q3’24 Nov '24, counts as said | 2 times: FDA, Q4’24 Feb '25, counts as said | 0 times: FDA, Q1’25 May '25 | 1 time: FDA, Q2’25 Aug '25, counts as said | 5 times: FDA, Q3’25 Nov '25, counts as said | 2 times: FDA, Q4’25 Feb '26, counts as said | 1 time: FDA, Q1’26 May '26, counts as said | 7 times: FDA, Q2’26 Aug '26, counts as said | rising | 7/888% | 4/850% | 8/2236% | 89%n=4+tx from settlement history blended with transcripts | 88¢ Kalshi |
| Eucalyptus | 0 times: Eucalyptus, Q3’24 Nov '24 | 0 times: Eucalyptus, Q4’24 Feb '25 | 0 times: Eucalyptus, Q1’25 May '25 | 0 times: Eucalyptus, Q2’25 Aug '25 | 0 times: Eucalyptus, Q3’25 Nov '25 | 15 times: Eucalyptus, Q4’25 Feb '26, counts as said | 5 times: Eucalyptus, Q1’26 May '26, counts as said | 12 times: Eucalyptus, Q2’26 Aug '26, counts as said | rising | 3/838% | 3/838% | 3/2214% | 88%n=1+tx from settlement history blended with transcripts | 88¢ Kalshi |
| Longevity | 0 times: Longevity, Q3’24 Nov '24 | 0 times: Longevity, Q4’24 Feb '25 | 4 times: Longevity, Q1’25 May '25, counts as said | 1 time: Longevity, Q2’25 Aug '25, counts as said | 11 times: Longevity, Q3’25 Nov '25, counts as said | 1 time: Longevity, Q4’25 Feb '26, counts as said | 2 times: Longevity, Q1’26 May '26, counts as said | 5 times: Longevity, Q2’26 Aug '26, counts as said | rising | 6/875% | 4/850% | 9/2241% | 87%n=1+tx from settlement history blended with transcripts | 86¢ Kalshi |
| Wegovy | 0 times: Wegovy, Q3’24 Nov '24 | 0 times: Wegovy, Q4’24 Feb '25 | 5 times: Wegovy, Q1’25 May '25, counts as said | 0 times: Wegovy, Q2’25 Aug '25 | 3 times: Wegovy, Q3’25 Nov '25, counts as said | 0 times: Wegovy, Q4’25 Feb '26 | 7 times: Wegovy, Q1’26 May '26, counts as said | 2 times: Wegovy, Q2’26 Aug '26, counts as said | rising | 4/850% | 3/838% | 4/2218% | 79%n=1+tx from settlement history blended with transcripts | 88¢ Kalshi |
| Canada / Canadian | 0 times: Canada / Canadian, Q3’24 Nov '24 | 0 times: Canada / Canadian, Q4’24 Feb '25 | 0 times: Canada / Canadian, Q1’25 May '25 | 13 times: Canada / Canadian, Q2’25 Aug '25, counts as said | 5 times: Canada / Canadian, Q3’25 Nov '25, counts as said | 3 times: Canada / Canadian, Q4’25 Feb '26, counts as said | 2 times: Canada / Canadian, Q1’26 May '26, counts as said | 4 times: Canada / Canadian, Q2’26 Aug '26, counts as said | rising | 5/862% | 5/862% | 6/2227% | 78%transcripts from the transcript model | 78¢ Kalshi |
| Wearable | 0 times: Wearable, Q3’24 Nov '24 | 1 time: Wearable, Q4’24 Feb '25, counts as said | 1 time: Wearable, Q1’25 May '25, counts as said | 2 times: Wearable, Q2’25 Aug '25, counts as said | 0 times: Wearable, Q3’25 Nov '25 | 3 times: Wearable, Q4’25 Feb '26, counts as said | 3 times: Wearable, Q1’26 May '26, counts as said | 2 times: Wearable, Q2’26 Aug '26, counts as said | rising | 6/875% | 6/875% | 6/2227% | 78%n=1+tx from settlement history blended with transcripts | 75¢ Kalshi |
| Australia | 0 times: Australia, Q3’24 Nov '24 | 0 times: Australia, Q4’24 Feb '25 | 0 times: Australia, Q1’25 May '25 | 0 times: Australia, Q2’25 Aug '25 | 2 times: Australia, Q3’25 Nov '25, counts as said | 5 times: Australia, Q4’25 Feb '26, counts as said | 2 times: Australia, Q1’26 May '26, counts as said | 3 times: Australia, Q2’26 Aug '26, counts as said | rising | 4/850% | 4/850% | 5/2223% | 74%transcripts from the transcript model | 87¢ Kalshi |
| Collaboration | 0 times: Collaboration, Q3’24 Nov '24 | 0 times: Collaboration, Q4’24 Feb '25 | 10 times: Collaboration, Q1’25 May '25, counts as said | 1 time: Collaboration, Q2’25 Aug '25, counts as said | 3 times: Collaboration, Q3’25 Nov '25, counts as said | 0 times: Collaboration, Q4’25 Feb '26 | 1 time: Collaboration, Q1’26 May '26, counts as said | 2 times: Collaboration, Q2’26 Aug '26, counts as said | steady | 5/862% | 5/862% | 9/2241% | 71%n=4+tx from settlement history blended with transcripts | 66¢ Kalshi |
| Zava | 0 times: Zava, Q3’24 Nov '24 | 0 times: Zava, Q4’24 Feb '25 | 0 times: Zava, Q1’25 May '25 | 13 times: Zava, Q2’25 Aug '25, counts as said | 5 times: Zava, Q3’25 Nov '25, counts as said | 5 times: Zava, Q4’25 Feb '26, counts as said | 1 time: Zava, Q1’26 May '26, counts as said | 0 times: Zava, Q2’26 Aug '26 | steady | 4/850% | 4/850% | 4/2218% | 66%n=4+tx from settlement history blended with transcripts | 42¢ Kalshi |
| Europe | 0 times: Europe, Q3’24 Nov '24 | 0 times: Europe, Q4’24 Feb '25 | 0 times: Europe, Q1’25 May '25 | 1 time: Europe, Q2’25 Aug '25, counts as said | 2 times: Europe, Q3’25 Nov '25, counts as said | 1 time: Europe, Q4’25 Feb '26, counts as said | 0 times: Europe, Q1’26 May '26 | 2 times: Europe, Q2’26 Aug '26, counts as said | rising | 4/850% | 4/850% | 5/2223% | 64%n=4+tx from settlement history blended with transcripts | 68¢ Kalshi |
| Cancer | 0 times: Cancer, Q3’24 Nov '24 | 0 times: Cancer, Q4’24 Feb '25 | 1 time: Cancer, Q1’25 May '25, counts as said | 0 times: Cancer, Q2’25 Aug '25 | 3 times: Cancer, Q3’25 Nov '25, counts as said | 1 time: Cancer, Q4’25 Feb '26, counts as said | 0 times: Cancer, Q1’26 May '26 | 0 times: Cancer, Q2’26 Aug '26 | steady | 3/838% | 1/812% | 4/2218% | 40%n=3+tx from settlement history blended with transcripts | 22¢ Kalshi |
| Microdose / Microdosing | 0 times: Microdose / Microdosing, Q3’24 Nov '24 | 0 times: Microdose / Microdosing, Q4’24 Feb '25 | 0 times: Microdose / Microdosing, Q1’25 May '25 | 0 times: Microdose / Microdosing, Q2’25 Aug '25 | 1 time: Microdose / Microdosing, Q3’25 Nov '25, counts as said | 0 times: Microdose / Microdosing, Q4’25 Feb '26 | 0 times: Microdose / Microdosing, Q1’26 May '26 | 0 times: Microdose / Microdosing, Q2’26 Aug '26 | steady | 1/812% | 1/812% | 1/225% | 18%n=3+tx from settlement history blended with transcripts | 10¢ Kalshi |
| Galennever said | 0 times: Galen, Q3’24 Nov '24 | 0 times: Galen, Q4’24 Feb '25 | 0 times: Galen, Q1’25 May '25 | 0 times: Galen, Q2’25 Aug '25 | 0 times: Galen, Q3’25 Nov '25 | 0 times: Galen, Q4’25 Feb '26 | 0 times: Galen, Q1’26 May '26 | 0 times: Galen, Q2’26 Aug '26 | steady | 0/80% | 0/80% | 0/220% | 17%transcripts from the transcript model | 32¢ Kalshi |
| Amazon | 0 times: Amazon, Q3’24 Nov '24 | 1 time: Amazon, Q4’24 Feb '25, counts as said | 1 time: Amazon, Q1’25 May '25, counts as said | 2 times: Amazon, Q2’25 Aug '25, counts as said | 0 times: Amazon, Q3’25 Nov '25 | 0 times: Amazon, Q4’25 Feb '26 | 0 times: Amazon, Q1’26 May '26 | 0 times: Amazon, Q2’26 Aug '26 | falling | 3/838% | 3/838% | 3/2214% | 16%n=4+tx from settlement history blended with transcripts | 12¢ Kalshi |
| Regulation | 0 times: Regulation, Q3’24 Nov '24 | 1 time: Regulation, Q4’24 Feb '25, counts as said | 3 times: Regulation, Q1’25 May '25, counts as said | 0 times: Regulation, Q2’25 Aug '25 | 0 times: Regulation, Q3’25 Nov '25 | 0 times: Regulation, Q4’25 Feb '26 | 0 times: Regulation, Q1’26 May '26 | 0 times: Regulation, Q2’26 Aug '26 | falling | 2/825% | 0/80% | 3/2214% | 15%n=4+tx from settlement history blended with transcripts | 18¢ Kalshi |
- times said on that call
- counted as said (ring)
- no call
- probability next time, with n
- Select a word or a cell for its quotes
What the columns mean
- Last N
- of the appearances shown, how many counted as said
- Trend
- how the count moved over these calls
- Scripted
- calls of the last 8 where it was said in the prepared remarks
- All-time
- every call on file
- Probability
- the calibrated probability for the next listing; n is the settled observations behind it when it was computed, '+tx' adds the transcripts, 'new' means too little history
Market prices are mid quotes from Kalshi and Polymarket, shown for context, may be delayed by several minutes and are not a signal. Quotes as of Oct 21, 2026 16:21 UTC.
Every word
1–11 of 11, most settled first| Word | Q3’24Nov '24 | Q4’24Feb '25 | Q1’25May '25 | Q2’25Aug '25 | Q3’25Nov '25 | Q4’25Feb '26 | Q1’26May '26 | Q2’26last call | Trend | Last 8 | Scripted | All-time | Probability |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Canada | 0 times: Canada, Q3’24 Nov '24 | 0 times: Canada, Q4’24 Feb '25 | 0 times: Canada, Q1’25 May '25 | 6 times: Canada, Q2’25 Aug '25, counts as said | 4 times: Canada, Q3’25 Nov '25, counts as said | 3 times: Canada, Q4’25 Feb '26, counts as said | 2 times: Canada, Q1’26 May '26, counts as said | 4 times: Canada, Q2’26 Aug '26, counts as said | rising | 5/862% | 5/862% | 6/2227% | 84%n=4+tx from settlement history blended with transcripts |
| Vitamin | 0 times: Vitamin, Q3’24 Nov '24 | 4 times: Vitamin, Q4’24 Feb '25, counts as said | 3 times: Vitamin, Q1’25 May '25, counts as said | 2 times: Vitamin, Q2’25 Aug '25, counts as said | 1 time: Vitamin, Q3’25 Nov '25, counts as said | 1 time: Vitamin, Q4’25 Feb '26, counts as said | 0 times: Vitamin, Q1’26 May '26 | 0 times: Vitamin, Q2’26 Aug '26 | falling | 5/862% | 5/862% | 6/2227% | 38%n=4+tx from settlement history blended with transcripts |
| Tariff | 0 times: Tariff, Q3’24 Nov '24 | 0 times: Tariff, Q4’24 Feb '25 | 1 time: Tariff, Q1’25 May '25, counts as said | 3 times: Tariff, Q2’25 Aug '25, counts as said | 0 times: Tariff, Q3’25 Nov '25 | 0 times: Tariff, Q4’25 Feb '26 | 0 times: Tariff, Q1’26 May '26 | 0 times: Tariff, Q2’26 Aug '26 | falling | 2/825% | 1/812% | 2/229% | 15%n=4+tx from settlement history blended with transcripts |
| GLP-1 | 51 times: GLP-1, Q3’24 Nov '24, counts as said | 25 times: GLP-1, Q4’24 Feb '25, counts as said | 5 times: GLP-1, Q1’25 May '25, counts as said | 17 times: GLP-1, Q2’25 Aug '25, counts as said | 11 times: GLP-1, Q3’25 Nov '25, counts as said | 21 times: GLP-1, Q4’25 Feb '26, counts as said | 8 times: GLP-1, Q1’26 May '26, counts as said | 1 time: GLP-1, Q2’26 Aug '26, counts as said | falling | 8/8100% | 7/888% | 13/2259% | 95%n=1+tx from settlement history blended with transcripts |
| Peptide5+ times | 0 times: Peptide 5+ times, Q3’24 Nov '24 | 6 times: Peptide 5+ times, Q4’24 Feb '25, counts as said | 6 times: Peptide 5+ times, Q1’25 May '25, counts as said | 1 time: Peptide 5+ times, Q2’25 Aug '25, below the threshold | 8 times: Peptide 5+ times, Q3’25 Nov '25, counts as said | 3 times: Peptide 5+ times, Q4’25 Feb '26, below the threshold | 18 times: Peptide 5+ times, Q1’26 May '26, counts as said | 17 times: Peptide 5+ times, Q2’26 Aug '26, counts as said | rising | 5/862% | 5/862% | 5/2223% | 76%n=1+tx from settlement history blended with transcripts |
| Platformevery call 10+ times | 69 times: Platform 10+ times, Q3’24 Nov '24, counts as said | 66 times: Platform 10+ times, Q4’24 Feb '25, counts as said | 39 times: Platform 10+ times, Q1’25 May '25, counts as said | 39 times: Platform 10+ times, Q2’25 Aug '25, counts as said | 27 times: Platform 10+ times, Q3’25 Nov '25, counts as said | 39 times: Platform 10+ times, Q4’25 Feb '26, counts as said | 56 times: Platform 10+ times, Q1’26 May '26, counts as said | 45 times: Platform 10+ times, Q2’26 Aug '26, counts as said | steady | 8/8100% | 8/8100% | 22/22100% | 90%n=1+tx from settlement history blended with transcripts |
| Quarterevery call 20+ times | 70 times: Quarter 20+ times, Q3’24 Nov '24, counts as said | 44 times: Quarter 20+ times, Q4’24 Feb '25, counts as said | 45 times: Quarter 20+ times, Q1’25 May '25, counts as said | 67 times: Quarter 20+ times, Q2’25 Aug '25, counts as said | 44 times: Quarter 20+ times, Q3’25 Nov '25, counts as said | 24 times: Quarter 20+ times, Q4’25 Feb '26, counts as said | 35 times: Quarter 20+ times, Q1’26 May '26, counts as said | 52 times: Quarter 20+ times, Q2’26 Aug '26, counts as said | falling | 8/8100% | 8/8100% | 22/22100% | 82%n=1+tx from settlement history blended with transcripts |
| Subscriber15+ times | 40 times: Subscriber 15+ times, Q3’24 Nov '24, counts as said | 31 times: Subscriber 15+ times, Q4’24 Feb '25, counts as said | 41 times: Subscriber 15+ times, Q1’25 May '25, counts as said | 38 times: Subscriber 15+ times, Q2’25 Aug '25, counts as said | 21 times: Subscriber 15+ times, Q3’25 Nov '25, counts as said | 23 times: Subscriber 15+ times, Q4’25 Feb '26, counts as said | 21 times: Subscriber 15+ times, Q1’26 May '26, counts as said | 22 times: Subscriber 15+ times, Q2’26 Aug '26, counts as said | falling | 8/8100% | 8/8100% | 15/2268% | 78%n=1+tx from settlement history blended with transcripts |
| Fiscalnever said 10+ times | 0 times: Fiscal 10+ times, Q3’24 Nov '24 | 4 times: Fiscal 10+ times, Q4’24 Feb '25, below the threshold | 2 times: Fiscal 10+ times, Q1’25 May '25, below the threshold | 0 times: Fiscal 10+ times, Q2’25 Aug '25 | 0 times: Fiscal 10+ times, Q3’25 Nov '25 | 3 times: Fiscal 10+ times, Q4’25 Feb '26, below the threshold | 0 times: Fiscal 10+ times, Q1’26 May '26 | 2 times: Fiscal 10+ times, Q2’26 Aug '26, below the threshold | steady | 0/80% | 0/80% | 0/220% | 6%n=1+tx from settlement history blended with transcripts |
| Shutdown / Shut Downnever said | 0 times: Shutdown / Shut Down, Q3’24 Nov '24 | 0 times: Shutdown / Shut Down, Q4’24 Feb '25 | 0 times: Shutdown / Shut Down, Q1’25 May '25 | 0 times: Shutdown / Shut Down, Q2’25 Aug '25 | 0 times: Shutdown / Shut Down, Q3’25 Nov '25 | 0 times: Shutdown / Shut Down, Q4’25 Feb '26 | 0 times: Shutdown / Shut Down, Q1’26 May '26 | 0 times: Shutdown / Shut Down, Q2’26 Aug '26 | steady | 0/80% | 0/80% | 0/220% | 14%n=1+tx from settlement history blended with transcripts |
| YourBio | 0 times: YourBio, Q3’24 Nov '24 | 0 times: YourBio, Q4’24 Feb '25 | 0 times: YourBio, Q1’25 May '25 | 0 times: YourBio, Q2’25 Aug '25 | 0 times: YourBio, Q3’25 Nov '25 | 4 times: YourBio, Q4’25 Feb '26, counts as said | 3 times: YourBio, Q1’26 May '26, counts as said | 0 times: YourBio, Q2’26 Aug '26 | rising | 2/825% | 2/825% | 2/229% | 44%n=1+tx from settlement history blended with transcripts |
- times said on that call
- counted as said (ring)
- no call
- probability next time, with n
- Select a word or a cell for its quotes
What the columns mean
- Last N
- of the appearances shown, how many counted as said
- Trend
- how the count moved over these calls
- Scripted
- calls of the last 8 where it was said in the prepared remarks
- All-time
- every call on file
- Probability
- the calibrated probability for the next listing; n is the settled observations behind it when it was computed, '+tx' adds the transcripts, 'new' means too little history
Appearances and settled record
latest 12Our transcript counts matched how 86 of 86 settled words resolved (100.0%). How we check.
| Date | Appearance | Text | Words | Settled | Our count agreed |
|---|---|---|---|---|---|
| Aug 10, 2026 | Earnings call FY26 Q2 | Speaker-labelled transcript | 32 | 21 yes · 11 no | 32/32 (100%) |
| May 11, 2026 | Earnings call FY26 Q1 | Speaker-labelled transcript | 14 | 7 yes · 7 no | 14/14 (100%) |
| Feb 23, 2026 | Earnings call FY25 Q4 | Speaker-labelled transcript | 14 | 9 yes · 5 no | 14/14 (100%) |
| Nov 3, 2025 | Earnings call FY25 Q3 | Speaker-labelled transcript | 26 | 18 yes · 8 no | 26/26 (100%) |
| Aug 4, 2025 | Earnings call FY25 Q2 | Speaker-labelled transcript | 0 | – | – |
| May 5, 2025 | Earnings call FY25 Q1 | Speaker-labelled transcript | 0 | – | – |
| Feb 24, 2025 | Earnings call FY24 Q4 | Speaker-labelled transcript | 0 | – | – |
| Nov 4, 2024 | Earnings call FY24 Q3 | Speaker-labelled transcript | 0 | – | – |
| Aug 5, 2024 | Earnings call FY24 Q2 | Speaker-labelled transcript | 0 | – | – |
| May 6, 2024 | Earnings call FY24 Q1 | Speaker-labelled transcript | 0 | – | – |
| Feb 26, 2024 | Earnings call FY23 Q4 | Speaker-labelled transcript | 0 | – | – |
| Nov 6, 2023 | Earnings call FY23 Q3 | Speaker-labelled transcript | 0 | – | – |
Citeparrot.markets, “Hims (HIMS): earnings call word history”, as of Oct 23, 2026, https://parrot.markets/earnings/HIMS (CC BY 4.0)
Agents: this page as TSV at /api/v1/entity/hims · words: /api/v1/history?entity=hims · columnar JSON in #parrot-data · llms.txt · MCP